Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Acceptability of Low-Residue Diet Package (Enimaclin®) as Diet Control Before Colonoscopy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female~* Outpatient or healthy volunteer for health examination, 20\~75 years old~* Eligible for oral bowel preparation~* BMI (Body Mass Index) ≤ 30~Exclusion Criteria:~* Patients with severe constipation (as fewer than three stools per week)~* Patients with bowel obstruction~* Patients contraindicated with treatment drug~* Patients who need emergency medication~* Ineligible for bowel preparation~* Pregnant or breast-feeding~* Patients with known allergies to treatment drug or low-residue diet package~* Patients who are ineligible to enroll

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- low-residue diet package (Enimaclin®) (Type: EXPERIMENTAL): Low-residue diet package with normal amount 2L PEG-ELS
- Self-controlled diet (Type: PLACEBO_COMPARATOR): Self-controlled diet with normal amount of 2L PEG-ELS
- Low-residue diet (Enimaclin®) package (Type: EXPERIMENTAL): Low-residue diet package with low volume 1.5L PEG-ELS

Based on this trial design, predict the completion outcome and termination type (if applicable).